ELIXIR Innovation and SME Forum equips companies to advance personalised rare disease treatment

Developments in genomics have already been translated into personalised medicine and more effective treatments for rare diseases. National governments and companies are also investing in data-driven innovation that facilitates these prospects. To help companies access and take advantage of the wealth of data, ELIXIR organised a two-day ELIXIR Innovation and SME Forum on 14-15 November 2017 in Paris, France. The event attracted 75 participants working in large companies, SMEs, academia, patient associations, and European and French government agencies. Read more.

This entry was posted in ELIXIR.

Post a comment

Your email address will not be published. Required fields are marked *